Spero Therapeutics Inc.

NASDAQ: SPRO · Real-Time Price · USD
0.68
-0.01 (-1.45%)
At close: May 14, 2025, 3:59 PM
0.68
-0.03%
After-hours: May 14, 2025, 05:09 PM EDT

Spero Therapeutics Revenue

Spero Therapeutics reported an annual revenue of $27.4M, reflecting a -71.68% growth. For the quarter ending December 31, 2024, Spero Therapeutics generated $9.36M in revenue.
Revenue (ttm)
$27.4M
Revenue Growth
-71.68%
Price / Sales Ratio
2.03
Revenue / Employee
$856.13K
Employees
32
Market Cap
38.18M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.